Ribupatide
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apn
Fujian Shengdi Pharmaceutical Co · Phase 3 · Active, not recruiting · Enrollment 144
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.